<- Go Home
Parexel International Corporation
Parexel International Corporation operates as a biopharmaceutical outsourcing company that provides clinical research and logistics, medical communications, consulting, and technology products and services for pharmaceutical, biotechnology, and medical device industries worldwide.
Market Cap
EUR 4.5B
Volume
885.8K
Cash and Equivalents
EUR 302.7M
EBITDA
EUR 340.1M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
EUR 740.1M
Profit Margin
34.95%
52 Week High
EUR 88.10
52 Week Low
EUR 51.16
Dividend
N/A
Price / Book Value
7.09
Price / Earnings
42.76
Price / Tangible Book Value
-108.19
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
EUR 233.7M
Return on Equity
16.93%
Return on Assets
6.72
Cash and Short Term Investments
EUR 302.7M
Debt
EUR 671.5M
Equity
EUR 634.5M
Revenue
EUR 2.1B
Unlevered FCF
EUR 255.3M
Sector
Life Sciences Tools and Services
Category
N/A